Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validity of Targeted Next-Generation Sequencing in Routine Care for Identifying Clinically Relevant Molecular Profiles in Non-Small-Cell Lung Cancer: Results of a 2-Year Experience on 1343 Samples.
Legras A, Barritault M, Tallet A, Fabre E, Guyard A, Rance B, Digan W, Pecuchet N, Giroux-Leprieur E, Julie C, Jouveshomme S, Duchatelle V, Giraudet V, Gibault L, Cazier A, Pastre J, Le Pimpec-Barthes F, Laurent-Puig P, Blons H. Legras A, et al. Among authors: julie c. J Mol Diagn. 2018 Jul;20(4):550-564. doi: 10.1016/j.jmoldx.2018.04.002. Epub 2018 May 19. J Mol Diagn. 2018. PMID: 29787863 Free article.
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.
Giroux Leprieur E, Herbretau G, Dumenil C, Julie C, Giraud V, Labrune S, Dumoulin J, Tisserand J, Emile JF, Blons H, Chinet T. Giroux Leprieur E, et al. Among authors: julie c. Oncoimmunology. 2018 Jan 29;7(5):e1424675. doi: 10.1080/2162402X.2018.1424675. eCollection 2018. Oncoimmunology. 2018. PMID: 29721388 Free PMC article.
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.
Ouaknine Krief J, Helly de Tauriers P, Dumenil C, Neveux N, Dumoulin J, Giraud V, Labrune S, Tisserand J, Julie C, Emile JF, Chinet T, Giroux Leprieur E. Ouaknine Krief J, et al. Among authors: julie c. J Immunother Cancer. 2019 Jul 10;7(1):176. doi: 10.1186/s40425-019-0658-1. J Immunother Cancer. 2019. PMID: 31292005 Free PMC article.
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.
Taieb J, Zaanan A, Le Malicot K, Julié C, Blons H, Mineur L, Bennouna J, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Lepage C, Emile JF, Laurent-Puig P. Taieb J, et al. Among authors: julie c. JAMA Oncol. 2016 May 1;2(5):643-653. doi: 10.1001/jamaoncol.2015.5225. JAMA Oncol. 2016. PMID: 26768652
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
Giroux Leprieur E, Hélias-Rodzewicz Z, Takam Kamga P, Costantini A, Julie C, Corjon A, Dumenil C, Dumoulin J, Giraud V, Labrune S, Garinet S, Chinet T, Emile JF. Giroux Leprieur E, et al. Among authors: julie c. J Immunother Cancer. 2020 Jun;8(1):e000527. doi: 10.1136/jitc-2020-000527. J Immunother Cancer. 2020. PMID: 32581058 Free PMC article.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Blons H, Emile JF, Le Malicot K, Julié C, Zaanan A, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Nørgård-Petersen L, Van Cutsem E, Lepage C, Zawadi MA, Salazar R, Laurent-Puig P, Taieb J. Blons H, et al. Among authors: julie c. Ann Oncol. 2014 Dec;25(12):2378-2385. doi: 10.1093/annonc/mdu464. Epub 2014 Oct 6. Ann Oncol. 2014. PMID: 25294886 Free article. Clinical Trial.
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
Talb J, Takam Kamga P, Mayenga M, Costantini A, Julié C, Dumenil C, Dumoulin J, Ouaknine J, Giraud V, Dujon C, Azarian R, Glaser C, Emile JF, Giroux Leprieur E. Talb J, et al. Among authors: julie c. Cancer Immunol Immunother. 2022 Nov;71(11):2791-2799. doi: 10.1007/s00262-022-03206-4. Epub 2022 Apr 18. Cancer Immunol Immunother. 2022. PMID: 35435450 Free PMC article.
110 results